高度瘤芽是喉状细胞癌患者生存的危险因素
1Capital Medical University, Beijing Tongren Hospital, Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Department of Pathology, Beijing, China; Capital Medical University, Beijing Luhe Hospital, Department of Pathology, Beijing, China.
Brazilian journal of otorhinolaryngology
|September 7, 2023
概括
高度瘤芽是喉状细胞癌存活率的独立预后因素. 这一发现对整体存活率和早期疾病至关重要,影响了这种癌症的治疗策略.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 全球范围内喉状细胞癌 (LSCC) 的发病率和死亡率正在上升.
- 需要新的预后因素来改善患者的治疗结果,并防止疾病的进展.
研究的目的:
- 调查瘤芽是否是LSCC患者生存的独立风险因素.
主要方法:
- 在268个LSCC病例中分析瘤芽.
- 瘤芽与临床病理特征和临床结果的相关性.
- 多变量生存分析以确定预后意义.
主要成果:
- 高度瘤芽 (≥7/0.785毫米2) 与较小的瘤细胞巢,较低的瘤透淋巴细胞和较高的病理T阶段有关.
- 高度瘤芽独立预测LSCC中较差的无病生存率和整体生存率.
- 高度瘤芽也是早期 (T1-2N0) LSCC生存的重要预后因素.
结论:
- 瘤芽是LSCC的重要独立预后因素.
- 高度瘤芽对晚期和早期LSCC的生存有不利影响.
- 这一发现可以为LSCC患者的风险分层和治疗决策提供信息.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K


